Research published in two articles in this week’s The Lancethas demonstrated that moderate-to-severe psoriasis can be effectivelytreated with the drug ustekinumab. In these PHOENIX trials, the authorshave also shown that treatment every 12 weeks maintains efficacy inmost people.As the most common immune-mediated adult skin disease, psoriasisaffects nearly 2 to 3% of the population.

This post is an original post by ScienceDaily: Skin Care News

Posted: May 15th, 2008 under skin health.
Comments: none

The earliest event in the development of sun-induced skin cancer may have been identified. Researchers found that the point of entry for skin cancer in response to sun exposure is in receptor molecules, molecular “hooks” on the outer surface of cells that also pull cannabinoid compounds found in marijuana out of the bloodstream.

This post is an original post by ScienceDaily: Skin Care News

Posted: May 15th, 2008 under skin health.
Comments: none